Targeting Tumor-Related Immunosuppression for Cancer Immunotherapy

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|6|3|223-237

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.6, Iss.3, 2006-09, pp. : 223-237

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Brain Tumor-Related Epilepsy

By  

Current Neuropharmacology, Vol. 10, Iss. 2, 2012-06 ,pp. : 124-133

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Tumor Stroma in Cancer Therapy

By  

Current Pharmaceutical Biotechnology, Vol. 10, Iss. 2, 2009-02 ,pp. : 185-191

Bentham Science Publishers

Access to resources Recommend Favorite

Temozolomide-Based Dry Powder Formulations for Lung Tumor-Related Inhalation Treatment

By Wauthoz Nathalie   Deleuze Philippe   Saumet Amandine   Duret Christophe   Kiss Robert   Amighi Karim  

Pharmaceutical Research, Vol. 28, Iss. 4, 2011-04 ,pp. : 762-775

Springer Publishing Company

Access to resources Recommend Favorite

Targeting Tumor Suppressor Networks for Cancer Therapeutics

By  

Current Drug Targets, Vol. 15, Iss. 1, 2014-01 ,pp. : 2-16

Bentham Science Publishers

Access to resources Recommend Favorite

Intracellular Delivery of Tumor Antigenic Peptides in Biodegradablepolymer Adjuvant for Enhancing Cancer Immunotherapy

By  

Current Medicinal Chemistry, Vol. 21, Iss. 21, 2014-07 ,pp. : 2357-2366

Bentham Science Publishers

Access to resources Recommend Favorite